Preferred Label : Intensity and Distress 5;

NCIt synonyms : 5-Severe; Severe; 5;

NCIt related terms : 5 Severe;

NCIt definition : A subjective score of 5 on a symptom's intensity and distress scale that ranges from 1: Slight to 5: Severe.;

NCI Metathesaurus CUI : CL971162;

Details


Main resources

You can consult :


https://publications.msss.gouv.qc.ca/msss/document-003688/
2024
Canada
scientific and technical information
Fear Score 5
suicide
Upset Score 5
suicide, nos
ECOG Performance Status 5
Autonomic Nervous System
Thought Score 5
Severity of Symptom Score 5
Intensity and Distress 5
Suicide
Thirteen
Agreement Score 5
Loss of Chromosome 5
cues
Clinical Status Ordinal Scale Outcome 5
attentiveness
Phase V Trial
Death Related to Adverse Event
Child
Gleason Grade Group 5
Offspring
Illness Intrusiveness Rating 5
Current Reformed Smoker, Years Unknown
child
business
commerce
child, nos
Neck Pain Score 5

---
https://www.ce-mir.fr/files/medias/documents/45.%20Infections%20cutan%C3%A9omuqueuses%20s%C3%A9v%C3%A8res.pdf
2024
France
educational course
Severe Adverse Event
Epidermal cGVHD Score 4
Intensity and Distress 5
Severe Extremity Pain
severe
Severe Dysplasia
Borg Category-Ratio 10 Perceived Exertion Score 5
Infections
Severe Hallucination
infectious disease, nos
Infection

---
https://www.ce-mir.fr/files/medias/documents/39.%20Hypercalc%C3%A9mie%20aigu%C3%AB%20s%C3%A9v%C3%A8re.pdf
2024
France
educational course
Epidermal cGVHD Score 4
hypercalcemia
Hypercalcemia, CTCAE
Intensity and Distress 5
Severe Extremity Pain
Severe Hallucination
Severe Adverse Event
Borg Category-Ratio 10 Perceived Exertion Score 5
hypercalcemia
severe
Hypercalcemia
Severe Dysplasia

---
https://www.ce-mir.fr/files/medias/documents/23.%20Exacerbation%20s%C3%A9v%C3%A8re%20d%27asthme.pdf
2024
France
educational course
asthma, nos
Severe Adverse Event
Severe Hallucination
Asthma Pathway
asthma
Borg Category-Ratio 10 Perceived Exertion Score 5
Asthma
Intensity and Distress 5
Severe Extremity Pain
severe
Severe Dysplasia
Epidermal cGVHD Score 4
asthma
Exacerbation

---
https://www.canal-u.tv/chaines/ub/jeu-de-maux-episode-5-l-etymologie-la-terminologie-des-mots-de-la-dermatologie-partie-2
2024
France
audiovisual aids
ECOG Performance Status 5
Phase V Trial
Illness Intrusiveness Rating 5
terminology as topic
Clinical Status Ordinal Scale Outcome 5
Intensity and Distress 5
Fear Score 5
Death Related to Adverse Event
etymology
Loss of Chromosome 5
Nomenclature
Episode
terminology
Dermatologist
Upset Score 5
episode of
Neck Pain Score 5
dermatology
Severity of Symptom Score 5
Thought Score 5
Current Reformed Smoker, Years Unknown
Terminology
Agreement Score 5
Gleason Grade Group 5
Integumentary System Finding

---
https://www.cochrane.org/fr/CD015328/PUBHLTH_les-strategies-en-matiere-dalimentation-et-dactivite-contribuent-elles-prevenir-lobesite-chez-les
2024
United Kingdom
review of literature
french abstract
child, nos
attentiveness
Obese
Child
Current Reformed Smoker, Years Unknown
Upset Score 5
Eleven
Loss of Chromosome 5
ECOG Performance Status 5
FDA Establishment Activity Terminology
Severity of Symptom Score 5
obesity
diet
Strategy
Gleason Grade Group 5
Biochemical Activity
Autonomic Nervous System
Phase V Trial
Feed
Obesity
food
Illness Intrusiveness Rating 5
pediatric obesity
Loss of Chromosome 11
Fear Score 5
Offspring
obesity
Agreement Score 5
GDC Procedures Performed Terminology
Thought Score 5
obesity, nos
Clinical Status Ordinal Scale Outcome 5
Active
Neck Pain Score 5
Intensity and Distress 5
Feeding
What Month is it
child
Obesity, CTCAE
eating, nos
Death Related to Adverse Event

---
https://minerva-ebp.be/FR/Article/2381
2024
France
critical appraisal or critical reading
Personalized
Severe Dysplasia
duration
medical futility
severe
Limited Walking Ability
Exercise Pain Management
Limited
Rheumatoid Arthritis
Individualized
Exercise
Limiter Device
Epidermal cGVHD Score 4
Management
Severe Extremity Pain
Severe Hallucination
Limited Lifting Ability
Long-Term
supervision
Intensity and Distress 5
Before Exercise
Severe Adverse Event
Polyarthritis
organization and administration
Extremities
Borg Category-Ratio 10 Perceived Exertion Score 5
exercise
arthritis, rheumatoid

---
https://www.cochrane.org/fr/CD009531/SCHIZ_modeles-de-soins-collaboratifs-chez-les-patients-atteints-de-troubles-mentaux-severes
2024
United Kingdom
review of literature
french abstract
severe
Epidermal cGVHD Score 4
Disease or Disorder
Severe Hallucination
Intensity and Distress 5
patient care
has patient
Severe Dysplasia
mental disorder, nos
Collaboration
Patterns of Care
cooperative behavior
Patient Care
Persons with Psychiatric Disorders
Borg Category-Ratio 10 Perceived Exertion Score 5
mental disorders
Severe Extremity Pain
Severe Adverse Event

---
https://www.reseau-naissance.fr/medias/2016/12/Anesthesie-chez-parturiente-obese-severe-PRO_012-RSN.pdf
2024
France
guideline
Delivery of Placenta
morbidity
parturition
Borg Category-Ratio 10 Perceived Exertion Score 5
anesthesia
Severe Hallucination
Water Delivery
lack of sensation
obesity
Severe Dysplasia
FBXW4 wt Allele
Intensity and Distress 5
Delivery
Epidermal cGVHD Score 4
Severe Extremity Pain
Anesthesia Procedure
parturition, nos
Obese
Transfer
Birth
Severe Adverse Event
Benzocaine
severe

---
https://www.has-sante.fr/jcms/p_3511384/fr/odm-5
2024
France
health technology assessment
solution, nos
Agreement Score 5
Topical Solution Dosage Form
Thought Score 5
ophthalmic solutions
Fear Score 5
ECOG Performance Status 5
Sterile
sterility, nos
ophthalmitis, nos
Current Reformed Smoker, Years Unknown
Gleason Grade Group 5
Clinical Status Ordinal Scale Outcome 5
Prednisone
Loss of Chromosome 5
Death Related to Adverse Event
Ophthalmic Solution
Infertility
Ophthalmic Solution Dosage Form
Severity of Symptom Score 5
Illness Intrusiveness Rating 5
Usage
Neck Pain Score 5
Phase V Trial
Intensity and Distress 5
Upset Score 5

---
https://www.has-sante.fr/jcms/p_3490837/fr/esbriet-pirfenidone-fibrose-pulmonaire-idiopathique-fpi-severe
2024
false
false
false
France
evaluation of the transparency committee
Borg Category-Ratio 10 Perceived Exertion Score 5
Epidermal cGVHD Score 4
fibrosis of lung, nos
Severe Adverse Event
Pirfenidone
idiopathic pulmonary fibrosis
severe
esbriet
Severe Dysplasia
pirfenidone
unknown (origin)
Severe Hallucination
Idiopathic Pulmonary Fibrosis
Severe Extremity Pain
Intensity and Distress 5
pirfenidone

---
https://www.has-sante.fr/jcms/p_3496700/fr/omnipod-5-pompe-a-insuline-et-controleur-omnipod-5-systeme-de-mesure-du-glucose-interstitiel-dexcom-g6
2024
France
health technology assessment
Mercaptopurine/Methotrexate/Methylprednisolone/Vincristine
weights and measures
System of Measurement
Pump Device
Upset Score 5
Insulin Measurement
insulin pump, nos
Glucose Measurement
Type 1 Diabetes Mellitus
diabetes mellitus, type 1
Insulin
Pump
Intensity and Distress 5
Illness Intrusiveness Rating 5
Cryptogenic Organizing Pneumonia
glucose
Management Occupations
Management
robot
State Machine
Phase V Trial
glucose, nos
Severity of Symptom Score 5
insulin infusion systems
Mercaptopurine/Methotrexate/Prednisolone/Vincristine
Neck Pain Score 5
Fear Score 5
Current Reformed Smoker, Years Unknown
glucose
Controller Device
ECOG Performance Status 5
Thought Score 5
Automatic
measures
Gleason Grade Group 5
automatism
Interstitial Route of Administration
Anemia of Prematurity
Agreement Score 5
Death Related to Adverse Event
Therapeutic Insulin
Loss of Chromosome 5
automatism
Epirubicin/Prednisone/Vincristine
Clinical Status Ordinal Scale Outcome 5

---
https://www.ce-mir.fr/files/medias/documents/57.%20Traumatismes%20s%C3%A9v%C3%A8res_0.pdf
2024
France
educational course
wounds and injuries
severe
Severe Adverse Event
Intensity and Distress 5
Severe Dysplasia
Severe Extremity Pain
Borg Category-Ratio 10 Perceived Exertion Score 5
Epidermal cGVHD Score 4
Injury
injury, nos
Severe Hallucination

---
https://www.has-sante.fr/jcms/p_3508871/fr/icesphere-1-5-cx-90
2024
France
health technology assessment
Neck Pain Score 1
One Hundred Percent
Never Smoker
Agreement Score 5
Severity of Symptom Score 1
Gleason Grade Group 1
ECOG Performance Status 1
Thought Score 5
Intensity and Distress 5
needles
Fear Score 5
Severity of Symptom Score 5
Symptoms Extent Score 1
Lansky Performance Status 90
Gleason Grade Group 5
One Full Term Pregnancy
CDISC SDTM Model Version 1.6
CDISC SDTM Model Version 1.5
Tumor Regression Score 1
Christmas Island
Illness Intrusiveness Rating 1
Loss of Chromosome 5
Capecitabine/Cisplatin Regimen
Clinical Status Ordinal Scale Outcome 1
Nebulizer Solution Dosage Form
Agreement Score 1
Phase V Trial
Cryosurgery
Fear Score 1
Clinical Status Ordinal Scale Outcome 5
Mild Adverse Event
Thought Score 1
Current Reformed Smoker, Years Unknown
Cryoablation for Arrhythmia
Upset Score 1
Karnofsky Performance Status 90
Solomon Islands
One
Cryoablation
1+ Score
Neck Pain Score 5
Death Related to Adverse Event
ECOG Performance Status 5
Phase I Trial
cryosurgery
needle
1+ Score, WHO
Illness Intrusiveness Rating 5
Ninety
Intensity and Distress 1
railway signalman
Nebulizer Solution Dosage Form
Upset Score 5

---
https://www.has-sante.fr/jcms/p_3508889/fr/icerod-1-5-cx-90-et-icerod-1-5-mri-90
2024
France
health technology assessment
Tumor Regression Score 1
Gleason Grade Group 1
Mild Adverse Event
One
cryosurgery
Fear Score 5
Clinical Status Ordinal Scale Outcome 5
1+ Score, WHO
Cryoablation for Arrhythmia
Cryoablation
Clinical Status Ordinal Scale Outcome 1
railway signalman
Intensity and Distress 1
Upset Score 5
Thought Score 5
Intensity and Distress 5
ECOG Performance Status 5
Phase V Trial
CDISC SDTM Model Version 1.5
Thought Score 1
Ninety
Neck Pain Score 1
Phase I Trial
Fear Score 1
Nebulizer Solution Dosage Form
Christmas Island
Severity of Symptom Score 1
Neck Pain Score 5
One Full Term Pregnancy
Never Smoker
ECOG Performance Status 1
Symptoms Extent Score 1
Illness Intrusiveness Rating 5
1+ Score
needles
Current Reformed Smoker, Years Unknown
Cryosurgery
Nebulizer Solution Dosage Form
Lansky Performance Status 90
Death Related to Adverse Event
One Hundred Percent
Severity of Symptom Score 5
Agreement Score 5
Solomon Islands
Agreement Score 1
Karnofsky Performance Status 90
magnetic resonance imaging
Upset Score 1
Gleason Grade Group 5
needle
Capecitabine/Cisplatin Regimen
CDISC SDTM Model Version 1.6
Loss of Chromosome 5
Illness Intrusiveness Rating 1

---
https://www.has-sante.fr/jcms/p_3508904/fr/iceseed-1-5-90-et-iceseed-1-5-mri-90
2024
France
health technology assessment
Intensity and Distress 5
Karnofsky Performance Status 90
Loss of Chromosome 5
Agreement Score 1
Nebulizer Solution Dosage Form
needles
Phase V Trial
cryosurgery
Death Related to Adverse Event
ECOG Performance Status 5
Severity of Symptom Score 1
Upset Score 5
One Full Term Pregnancy
Never Smoker
magnetic resonance imaging
Cryoablation
railway signalman
Cryoablation for Arrhythmia
Agreement Score 5
Nebulizer Solution Dosage Form
Solomon Islands
Fear Score 1
ECOG Performance Status 1
Thought Score 1
Upset Score 1
1+ Score, WHO
Intensity and Distress 1
CDISC SDTM Model Version 1.5
Gleason Grade Group 1
Current Reformed Smoker, Years Unknown
Gleason Grade Group 5
Severity of Symptom Score 5
Clinical Status Ordinal Scale Outcome 5
Symptoms Extent Score 1
Clinical Status Ordinal Scale Outcome 1
needle
One
Fear Score 5
Illness Intrusiveness Rating 5
Tumor Regression Score 1
Neck Pain Score 1
Ninety
Lansky Performance Status 90
Thought Score 5
Neck Pain Score 5
One Hundred Percent
Cryosurgery
1+ Score
CDISC SDTM Model Version 1.6
Illness Intrusiveness Rating 1
Phase I Trial
Mild Adverse Event

---
https://dumas.ccsd.cnrs.fr/dumas-04485360
2023
France
dissertations, academic
Focus
educational status
Shield Device
exposure to
classification
Reasoning
Loss of Chromosome 5
Upset Score 5
Child
education
Thought Score 5
review literature as topic
asthenia
Illness Intrusiveness Rating 5
Systematic Review
Education Level
Intensity and Distress 5
Neck Pain Score 5
shield, nos
Clinical Status Ordinal Scale Outcome 5
Phase V Trial
Reviewing
Severity of Symptom Score 5
Fear Score 5
child, nos
thinking, nos
Autonomic Nervous System
Current Reformed Smoker, Years Unknown
Offspring
child
Low Level
ECOG Performance Status 5
Gleason Grade Group 5
Death Related to Adverse Event
What Month is it
Exposure Domain
Workhouses
Exposure
Agreement Score 5

---
https://www.has-sante.fr/jcms/p_3468959/fr/developpement-de-l-indicateur-sur-la-mesure-de-la-recuperation-de-5-complications-post-operatoires
2023
France
technical report
Maturation
postoperative complication, nos
Upset Score 5
Customize
ECOG Performance Status 5
suggestive of
Human Cells, Tissues, and Cellular and Tissue-Based Products Recovery
Operative
Agreement Score 5
Thought Score 5
Recovery
Measurement
Fear Score 5
Development Batch
postoperative complications
Indicator
Gleason Grade Group 5
Measured Tumor Identification
Complication
Intensity and Distress 5
Neck Pain Score 5
Death Related to Adverse Event
Loss of Chromosome 5
Severity of Symptom Score 5
Current Reformed Smoker, Years Unknown
Development Lot
measures
Measurement
Stock Recovery
Alpha-lipoic Acid/Boswellia Serrata Extract/Methylsulfonylmethane/Bromelain Dietary Supplement
Illness Intrusiveness Rating 5
indication of
Phase V Trial
indicators and reagents
Clinical Status Ordinal Scale Outcome 5
weights and measures

---
https://campus.neurochirurgie.fr/article1724.html
2023
France
educational course
central nervous system
Clinical Status Ordinal Scale Outcome 5
central nervous system
Primary Central Nervous System Lymphoma
Upset Score 5
Cerebral Lymphoma
Intensity and Distress 5
malignant lymphoma, nos
ECOG Performance Status 5
Severity of Symptom Score 5
Current Reformed Smoker, Years Unknown
Fear Score 5
Agreement Score 5
Loss of Chromosome 5
Phase V Trial
lymphoma
Illness Intrusiveness Rating 5
Gleason Grade Group 5
Thought Score 5
Neck Pain Score 5
Death Related to Adverse Event

---
https://www.has-sante.fr/jcms/p_3473151/fr/dupixent-fasenra-nucala-tezspire-et-xolair-dans-le-traitement-de-l-asthme-severe
2023
France
guidelines for drug use
No Treatment for Diabetes
Nucala
Omalizumab
Borg Category-Ratio 10 Perceived Exertion Score 5
Omalizumab
Treat
tezspire
Treatment
Treatment Study
Severe Hallucination
Intensity and Distress 5
Severe Adverse Event
During Treatment
Epidermal cGVHD Score 4
Asthma
Dupilumab
asthma
Fasenra
Asthma Pathway
xolair
severe
Severe Dysplasia
asthma, nos
On Treatment
GDC Treatment Frequency Terminology
Treatment Epoch
Therapy Object
Dupixent
asthma
Biomaterial Treatment
Severe Extremity Pain
Mepolizumab

---
https://minerva-ebp.be/FR/Analysis/833
2023
Belgium
critical appraisal or critical reading
Phase V Trial
Thought Score 5
Medication
physicians
ECOG Performance Status 5
Responsive Disease
Loss of Chromosome 5
Comparison
Artificial Intelligence
Fear Score 5
Neck Pain Score 5
Intensity and Distress 5
volunteers
Clinical Status Ordinal Scale Outcome 5
Severity of Symptom Score 5
Agreement Score 5
Public
Questioning
Death Related to Adverse Event
Current Reformed Smoker, Years Unknown
Pet Responds to Presence
Examination Questions
intelligence, nos
Response_Gloss
Upset Score 5
Illness Intrusiveness Rating 5
artificial intelligence
Gleason Grade Group 5

---
https://www.cochrane.org/fr/CD014089/MUSKEL_quels-sont-les-benefices-et-les-risques-des-medicaments-qui-augmentent-le-flux-sanguin-vers-les
2023
United Kingdom
review of literature
french abstract
Ratio
secondary raynaud's phenomenon
Increased
Current Reformed Smoker, Years Unknown
increased vascular flow
risks and benefits
Fear Score 5
Medication
Placebo
raynaud disease
What Month is it
Loss of Chromosome 5
Intensity and Distress 5
drug, nos
Flow
Extremities
Clinical Status Ordinal Scale Outcome 5
extremities
Version
research report
ECOG Performance Status 5
anthelmintics
Severity of Symptom Score 5
No Flow
Thought Score 5
raynaud phenomenon
Death Related to Adverse Event
Agreement Score 5
Illness Intrusiveness Rating 5
Raynaud Phenomenon
Gleason Grade Group 5
risk assessment
placebos
Phase V Trial
Regulatory Report
Phosphodiesterase Inhibitor
Neck Pain Score 5
phosphodiesterase 5 inhibitors
Upset Score 5
albumin/globulin ratio
Increase
Flux
GDC Therapeutic Agent Terminology

---
https://sante.gouv.fr/IMG/pdf/dgs-urgent_2023_24_covid-19_novavax.pdf
2023
France
scientific and technical information
Device
Neck Pain Score 5
vaccination
Never Smoker
Novavax
Fear Score 5
1+ Score
Set, Psychology
ECOG Performance Status 5
Agreement Score 5
Severity of Symptom Score 5
Neck Pain Score 1
Illness Intrusiveness Rating 1
Thought Score 5
Severity of Symptom Score 1
ECOG Performance Status 1
devices
laboratories
One Hundred Percent
Intensity and Distress 1
Illness Intrusiveness Rating 5
Phase I Trial
Thought Score 1
Loss of Chromosome 5
CDISC SDTM Model Version 1.5
One Full Term Pregnancy
rehabilitation
COVID-19 Vaccines
Adaptation
habilitation
Mild Adverse Event
vaccinia
Death Related to Adverse Event
Agreement Score 1
Clinical Status Ordinal Scale Outcome 5
adaptation, nos
Gleason Grade Group 5
COVID-19 Vaccine
Intensity and Distress 5
vaccines
COVID-19
Change
Upset Score 5
Upset Score 1
preventive immunization/medication
Current Reformed Smoker, Years Unknown
Fear Score 1
One
vaccination
Gleason Grade Group 1
CDISC SDTM Model Version 1.6
Phase V Trial
Clinical Status Ordinal Scale Outcome 1
vaccine, nos
1+ Score, WHO
Tumor Regression Score 1
device, nos
Symptoms Extent Score 1

---
https://www.cultures-sante.be/nos-outils/fiches-lisa/item/530-fiche-lisa-n-5-comment-rendre-un-lieu-d-accueil-favorable-a-l-exercice-de-la-litteratie-en-sante.html
2019
Belgium
scientific and technical information
Agreement Score 5
Favorable
Fear Score 5
Gleason Grade Group 5
Exercise Pain Management
Phase V Trial
Severity of Symptom Score 5
Upset Score 5
Before Exercise
Placement
ECOG Performance Status 5
What Month is it
Exercise
Literacy
Clinical Status Ordinal Scale Outcome 5
Loss of Chromosome 5
Current Reformed Smoker, Years Unknown
exercise
Put
Illness Intrusiveness Rating 5
Thought Score 5
Place
Intensity and Distress 5
health literacy
Neck Pain Score 5
Death Related to Adverse Event

---
https://pgtmsite.files.wordpress.com/2024/01/5-azacitidine_ad_protocole_versionfinale_site-public_20150720.pdf
2015
Canada
drug information
ECOG Performance Status 5
Agreement Score 5
Fear Score 5
Phase V Trial
Current Reformed Smoker, Years Unknown
Death Related to Adverse Event
Gleason Grade Group 5
Clinical Status Ordinal Scale Outcome 5
Upset Score 5
azacitidine
Thought Score 5
Severity of Symptom Score 5
Azacitidine
Loss of Chromosome 5
Neck Pain Score 5
Illness Intrusiveness Rating 5
Intensity and Distress 5

---
https://pgtmsite.files.wordpress.com/2024/01/5-azacitidine_ad_version-finale_site-public_20151112.pdf
2015
Canada
drug information
Gleason Grade Group 5
Thought Score 5
Agreement Score 5
Phase V Trial
Death Related to Adverse Event
Use
Severity of Symptom Score 5
myelodysplasia
Illness Intrusiveness Rating 5
Loss of Chromosome 5
Intensity and Distress 5
myelodysplastic syndromes
NCI CTEP SDC Myelodysplastic Syndrome Sub-Category Terminology
Analyzed
Analysis
Adult Myelodysplastic Syndrome
Clinical Status Ordinal Scale Outcome 5
Fear Score 5
Childhood Myelodysplastic Syndrome
Identifier
Description
azacitidine
Azacitidine
ECOG Performance Status 5
Current Reformed Smoker, Years Unknown
Neck Pain Score 5
Upset Score 5

---
Nous contacter.
09/05/2025


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.